Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAF Mutation-positive Metastatic Melanoma
Clinical trial NCT04489433 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04489433
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.